Condition
Ulcerative Proctosigmoiditis
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting1
Active Not Recruiting1
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07061899Active Not Recruiting
The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic Proctosigmoiditis
NCT06655415Recruiting
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
NCT03521232Phase 1Terminated
A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis
Showing all 3 trials